Reference no: EM133689426

Question

As a Doctor of Nursing Practice (DNP), one type of direct-to-consumer test I may encounter in my clinical environment is the cancer predisposition test. These tests are designed to detect genetic mutations. This genetic mutation may increase an individual's risk of developing certain types of cancer (Matejcic et al., 2020). Cancer predisposition tests are helpful as they provide valuable information about a person's genetic predisposition to cancer and provide guidance that aligns with personalized screening and strategies for prevention (Matejcic et al., 2020). Based on educating consumers about limitations, cancer implications, and cancer prediction tests, there is a need to first track the significance of genetic counseling before or after the tests. This leads to a pure understanding of the test result, which helps develop a prediction about the results (Manchanda et al., 2020). The results might indicate whether the climate might cause cancer, despite the risk that might come with it. The ethical consideration based on the cancer predisposition test data might entail the potential for psychological harm such that it helps in giving the potential patient information in line with the risk. This aligns with providing support and counseling for the individual to cope.